Literature DB >> 29744000

A Review of Transcatheter Closure of Patent Foramen Ovale.

John Neill1, C Huie Lin1.   

Abstract

A patent foramen ovale (PFO) is a common variant in cardiac anatomy found in 25% to 30% of U.S. adults. While PFOs are a normal part of fetal development and commonly seen in asymptomatic adults, they have been implicated in a variety of pathophysiologic conditions. The most clinically important of these is paradoxical embolization of venous thrombus resulting in stroke or systemic embolism. Various devices can be used to close PFOs via a transcatheter approach to prevent recurrent stroke. Data regarding the safety and effectiveness of these devices is rapidly evolving, with recent long-term results suggesting efficacy in preventing secondary stroke in carefully selected patients. This review discusses historical data on PFO occurrence and treatment, a risk score that can assess the likelihood of a stroke being attributable to a PFO, a variety of other conditions that may be linked to PFOs, and current research regarding the role transcatheter closure plays in their treatment.

Entities:  

Keywords:  cryptogenic stroke; intracardiac shunt; patent foramen ovale; transcatheter PFO closure

Mesh:

Year:  2017        PMID: 29744000      PMCID: PMC5935199          DOI: 10.14797/mdcj-13-3-152

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  30 in total

1.  Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale.

Authors:  Sandra Rea Torti; Michael Billinger; Markus Schwerzmann; Rolf Vogel; Rainer Zbinden; Stephan Windecker; Christian Seiler
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

2.  Balloon assessment of patent foramen ovale morphology and the modification of tunnels using a balloon detunnelisation technique.

Authors:  Mark S Spence; Arif A Khan; Michael J Mullen
Journal:  Catheter Cardiovasc Interv       Date:  2008-02-01       Impact factor: 2.692

3.  Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.

Authors:  Heinrich P Mattle; Stefan Evers; David Hildick-Smith; Werner J Becker; Helmut Baumgartner; Jeremy Chataway; Marek Gawel; Hartmut Göbel; Axel Heinze; Eric Horlick; Iqbal Malik; Simon Ray; Adam Zermansky; Oliver Findling; Stephan Windecker; Bernhard Meier
Journal:  Eur Heart J       Date:  2016-02-22       Impact factor: 29.983

4.  Effect of catheter-based patent foramen ovale closure on the occurrence of arterial bubbles in scuba divers.

Authors:  Jakub Honěk; Martin Srámek; Luděk Sefc; Jaroslav Januška; Jiří Fiedler; Martin Horváth; Aleš Tomek; Stěpán Novotný; Tomáš Honěk; Josef Veselka
Journal:  JACC Cardiovasc Interv       Date:  2014-03-14       Impact factor: 11.195

5.  Patent foramen ovale in young stroke patients.

Authors:  M W Webster; A M Chancellor; H J Smith; D L Swift; D N Sharpe; N M Bass; G L Glasgow
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

6.  Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community.

Authors:  I Meissner; J P Whisnant; B K Khandheria; P C Spittell; W M O'Fallon; R D Pascoe; M Enriquez-Sarano; J B Seward; J L Covalt; J D Sicks; D O Wiebers
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

7.  Long-Term Outcomes and Complications of Intracardiac Echocardiography-Assisted Patent Foramen Ovale Closure in 1,000 Consecutive Patients.

Authors:  Gianluca Rigatelli; Luigi Pedon; Roberto Zecchel; Fabio Dell'Avvocata; Antonio Carrozza; Marco Zennaro; Alberto Mazza; Marco Zuin; Monia Russo; Mario Zanchetta
Journal:  J Interv Cardiol       Date:  2016-08-08       Impact factor: 2.279

8.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

9.  Platypnoea-orthodeoxia syndrome, an underdiagnosed cause of hypoxaemia: four cases and the possible underlying mechanisms.

Authors:  M Nassif; H Lu; T C Konings; B J Bouma; A Vonk Noordegraaf; B Straver; N A Blom; S A Clur; A P C M Backx; M Groenink; S M Boekholdt; D R Koolbergen; M G Hazekamp; B J M Mulder; R J de Winter
Journal:  Neth Heart J       Date:  2015-11       Impact factor: 2.380

10.  Paradoxical Embolus Stuck in a Patent Foramen Ovale.

Authors:  Zaki Kohistani; Chris Probst
Journal:  Thorac Cardiovasc Surg Rep       Date:  2016-10-03
View more
  3 in total

Review 1.  New-onset atrial fibrillation following percutaneous closure of patent foramen ovale: a systematic review and meta-analysis.

Authors:  Laura Oliva; Ella Huszti; Madeleine Barker; Claudia Frankfurter; Ruth Hall; Eric Horlick; Lusine Abrahamyan
Journal:  J Interv Card Electrophysiol       Date:  2021-01-08       Impact factor: 1.900

2.  Developing a random forest algorithm to identify patent foramen ovale and atrial septal defects in Ontario administrative databases.

Authors:  Laura Oliva; Eric Horlick; Bo Wang; Ella Huszti; Ruth Hall; Lusine Abrahamyan
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-06       Impact factor: 2.796

3.  Patent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary Tse; William K K Wu; Jenny Chi Ling Lai; Mengqi Gong; George Bazoukis; Wing Tak Wong; Sunny Hei Wong; Konstantinos Lampropoulos; Adrian Baranchuk; Lap Ah Tse; Yunlong Xia; Guangping Li; Martin C S Wong; Yat Sun Chan; Nan Mu; Mei Dong; Tong Liu
Journal:  F1000Res       Date:  2017-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.